<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">All randomized patients were included in the efficacy and safety analyses. A logistic regression model was used to compare the treatment effect in achieving the efficacy target, adjusted for country and baseline peripheral blood CD34
 <sup>+</sup> cell count, with the WB arm as the reference. The two-sided test of significance had a Type I error rate of 0.05.
</p>
